A trial of MK 8628 for acute myeloid leukaemia and diffuse large B cell lymphoma

Please note

This trial is no longer recruiting patients. We hope to add results when they are available.

Overview

Cancer types:

Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, High grade lymphoma, Lymphoma, Non-Hodgkin lymphoma (NHL)

Status:

Closed

Phase:

Phase 1

Details

This trial is looking at MK 8628 for people with acute myeloid leukaemia (AML) and diffuse large B cell lymphoma (DLBCL) who have had previous treatment. Some people over 60 years old may have treatment as part of the trial even if they haven’t had previous treatment for their leukaemia or lymphoma.

Recruitment start: 15 July 2016

Recruitment end: 23 June 2017